Summary
37 / 100 · Bulios Score
What speaks for it
- Revenue grew by 12% a year over the last 3 years.
- Analysts expect revenue to grow by 11% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 5.8 years of operating profit.
- The share price is above the Bulios Fair Price.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to grow by 11%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $3.17M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 10
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $42.5 is 82% above today's price. 83% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Aortic Stent Grafts 36%
- On X 23%
- Preservation Services 22%
- Surgical Sealants 17%
- Other Products 1.8%
By region
- North America Segment 50%
- Europe, the Middle East, and Africa Segments 34%
- Asia Pacific Segment 10%
- Latin America Segment 5.4%
Aortic Stent Grafts brings in 36% of revenue.
Segments in detail